Axsome Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. 

CEO
Herriott Tabuteau
CEOHerriott Tabuteau
Employees
545
Employees545
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2012
Founded2012
Employees
545
Employees545

AXSM Key Statistics

Market cap
3.22B
Market cap3.22B
Price-Earnings ratio
-13.06
Price-Earnings ratio-13.06
Dividend yield
Dividend yield
Average volume
598.38K
Average volume598.38K
High today
$68.14
High today$68.14
Low today
$65.50
Low today$65.50
Open price
$65.50
Open price$65.50
Volume
887.83K
Volume887.83K
52 Week high
$98.40
52 Week high$98.40
52 Week low
$55.02
52 Week low$55.02

AXSM News

Simply Wall St 7d
Axsome Therapeutics, Inc.'s Price In Tune With Revenues - Simply Wall St

Axsome Therapeutics, Inc.'s ( ) price-to-sales (or "P/S") ratio of 12.1x might make it look like a strong sell right now compared to the Pharmaceuticals industr...

Axsome Therapeutics, Inc.'s Price In Tune With Revenues - Simply Wall St

Analyst ratings

88%

of 16 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.